Dysautonomic Phenotype in Male Patients With MECP2 Mutation (MECP2BOYS)
Dysautonomic Signs Among MECP2boys
Sponsor: University Hospital, Brest
This observational or N/A phase trial investigates Dysautonomia and MECP2-Related Severe Neonatal Encephalopathy and is currently ongoing. University Hospital, Brest leads this study, which shows 6 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Unknown
-
Sep 2024 — Sep 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Sep 2022 — Jul 2024 [monthly]
Unknown Status
Status: Not Yet Recruiting → Unknown Status
-
Jan 2021 — Sep 2022 [monthly]
Not Yet Recruiting
▶ Show 1 earlier version
-
Sep 2020 — Jan 2021 [monthly]
Not Yet Recruiting
First recorded
Aug 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Brest
For direct contact, visit the study record on ClinicalTrials.gov .